Leiden University Medical Center, Department of Paediatrics, Leiden, The Netherlands
Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Paediatric Endocrinology; National Diabetes Care and Research Center, Clinic of Diabetes, Rotterdam, The Netherlands
J Clin Res Pediatr Endocrinol. 2021 Feb 26;13(1):15-22. doi: 10.4274/jcrpe.galenos.2020.2020.0130. Epub 2020 Sep 17.
We hypothesized that modelling catch-up growth (CUG) as developed for coeliac disease (CD), might also fit CUG in adequately treated children with juvenile hypothyroidism (JHT) or growth hormone deficiency (GHD).
We used a monomolecular function for all available prepubertal data on height standard deviation score (HSDS) minus target height SDS (adjHSDS) in children with JHT (n=20) and GHD (n=18) on a conventional (CoD) or high GH dose (HD), based either on a national height reference with an age cut-off of 10 (girls) and 12 (boys) years (model 1) or prepubertal height reference values, if age (0) was ≥3, with no upper age limit (model 2).
The models could be fitted in 83-90% of cases; in other cases the HSDS decreased after several measurements, which violated the assumption of an irreversible growth process. In JHT, the rate constant (k) and adjHSDS (0) were lower than in CD (p=0.02), but adjHSDS (end) was similar. In GHD (model 1), k was lower than for CD (p=0.004) but similar to JHT, while adjHSDS (0) and adjHSDS (end) were similar to CD and JHT. Thus, the shape of CUG is similar for children with JHT and GHD, while children with CD had less growth deficit at start and a faster CUG. The differences in CUG parameters between GH dose subgroups did not reach statistical significance.
Modelling CUG of prepubertal children with JHT and GHD can be used for assessing the adequacy of CUG and the influence of clinical treatment modalities on its speed and magnitude.
我们假设,用于模拟乳糜泻(CD)追赶生长(CUG)的模型,也可能适用于接受充分治疗的青少年甲状腺功能减退症(JHT)或生长激素缺乏症(GHD)儿童的 CUG。
我们使用了单分子函数,根据国家身高参考值(年龄截止点为 10 岁女孩和 12 岁男孩)或青春期前身高参考值(如果年龄(0)≥3 岁,且无上限年龄限制),对 JHT(n=20)和 GHD(n=18)儿童所有可获得的青春期前身高标准差评分(HSDS)减去目标身高 SDS(adjHSDS)的预初数据进行了分析,包括接受常规(CoD)或高剂量 GH(HD)治疗的儿童。
模型可适用于 83-90%的病例;在其他情况下,HSDS 在几次测量后下降,这违反了生长过程不可逆的假设。在 JHT 中,速率常数(k)和 adjHSDS(0)低于 CD(p=0.02),但 adjHSDS(结束)相似。在 GHD(模型 1)中,k 低于 CD(p=0.004),但与 JHT 相似,而 adjHSDS(0)和 adjHSDS(结束)与 CD 和 JHT 相似。因此,JHT 和 GHD 儿童的 CUG 形状相似,而 CD 儿童的生长缺陷起始值较低,CUG 速度较快。GH 剂量亚组之间 CUG 参数的差异未达到统计学意义。
可用于评估 JHT 和 GHD 儿童 CUG 的充分性,以及临床治疗方式对其速度和幅度的影响。